Sustainable Growth Advisers’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
|
|||||
|
2023
Q4 | $204K | Sell |
|
|||||
|
2023
Q3 | $344M | Sell |
|
|||||
|
2023
Q2 | $302M | Sell |
|
|||||
|
2023
Q1 | $356M | Buy |
|
|||||
|
2022
Q4 | $312M | Sell |
|
|||||
|
2022
Q3 | $340M | Sell |
|
|||||
|
2022
Q2 | $304M | Buy |
|
|||||
|
2022
Q1 | $299M | Sell |
|
|||||
|
2021
Q4 | $577M | Sell |
|
|||||
|
2021
Q3 | $616M | Buy |
|
|||||
|
2021
Q2 | $496M | Buy |
|
|||||
|
2021
Q1 | $375M | Buy |
|
|||||
|
2020
Q4 | $330M | Buy |
|
|||||
|
2020
Q3 | $258M | Sell |
|
|||||
|
2020
Q2 | $326M | Buy |
|
|||||
|
2020
Q1 | $229M | Sell |
|
|||||
|
2019
Q4 | $258M | Sell |
|
|||||
|
2019
Q3 | $209M | Buy |
|
|||||
|
2019
Q2 | $229M | Sell |
|
|||||
|
2019
Q1 | $378M | Sell |
|
|||||
|
2018
Q4 | $347M | Sell |
|
|||||
|
2018
Q3 | $402M | Sell |
|
|||||
|
2018
Q2 | $348M | Sell |
|
|||||
|
2018
Q1 | $360M | Buy |
|
|||||
|
2017
Q4 | $332M | Buy |
|
|||||
|
2017
Q3 | $298M | Buy |
|
|||||
|
2017
Q2 | $302M | Buy |
|
|||||
|
2017
Q1 | $199M | Buy |
|
|||||
|
2016
Q4 | $167M | Buy |
|
|||||
|
2016
Q3 | $178M | Buy |
|
|||||
|
2016
Q2 | $145M | Buy |
|
|||||
|
2016
Q1 | $127M | Buy |
|
|||||
|
2015
Q4 | $120M | Buy |
|
|||||
|
2015
Q3 | $101M | Buy |
|
|||||
|
2015
Q2 | $104M | Buy |
|
|||||
|
2015
Q1 | $76.6M | Buy |
|
|||||
|
2014
Q4 | $67.7M | Sell |
|
|||||
|
2014
Q3 | $77.2M | Sell |
|
|||||
|
2014
Q2 | $72.4M | Buy |
|
|||||
|
2014
Q1 | $73M | Buy |
|
|||||
|
2013
Q4 | $33.2M | Sell |
|
|||||
|
2013
Q3 | $84.2M | Sell |
|
|||||
|
2013
Q2 | $63.4M | Buy |
|